Page last updated: 2024-10-26

emodin and Adenocarcinoma, Bronchiolo-Alveolar

emodin has been researched along with Adenocarcinoma, Bronchiolo-Alveolar in 1 studies

Emodin: Purgative anthraquinone found in several plants, especially RHAMNUS PURSHIANA. It was formerly used as a laxative, but is now used mainly as a tool in toxicity studies.
emodin : A trihydroxyanthraquinone that is 9,10-anthraquinone which is substituted by hydroxy groups at positions 1, 3, and 8 and by a methyl group at position 6. It is present in the roots and barks of numerous plants (particularly rhubarb and buckthorn), moulds, and lichens. It is an active ingredient of various Chinese herbs.

Adenocarcinoma, Bronchiolo-Alveolar: A carcinoma derived from epithelium of terminal bronchioles, in which the neoplastic tissue extends along the alveolar walls and grows in small masses within the alveoli. Involvement may be uniformly diffuse and massive, or nodular, or lobular. The neoplastic cells are cuboidal or columnar and form papillary structures. Mucin may be demonstrated in some of the cells and in the material in the alveoli, which also includes denuded cells. Metastases in regional lymph nodes, and in even more distant sites, are known to occur, but are infrequent. (From Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
"Upon emodin treatment, p53 is phosphorylated at Ser(15), which is accompanied by the ATM phosphorylation at Ser(1981)."1.35Emodin induces a reactive oxygen species-dependent and ATM-p53-Bax mediated cytotoxicity in lung cancer cells. ( Chang, JT; Hsu, SL; Lai, JM; Wen, CL, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lai, JM1
Chang, JT1
Wen, CL1
Hsu, SL1

Other Studies

1 other study available for emodin and Adenocarcinoma, Bronchiolo-Alveolar

ArticleYear
Emodin induces a reactive oxygen species-dependent and ATM-p53-Bax mediated cytotoxicity in lung cancer cells.
    European journal of pharmacology, 2009, Nov-25, Volume: 623, Issue:1-3

    Topics: Adenocarcinoma, Bronchiolo-Alveolar; Antineoplastic Agents; Apoptosis; Ataxia Telangiectasia Mutated

2009